Media
Latest News
WASHINGTON—Senators frustrated with Saudi Arabia following the killing of journalist Jamal Khashoggi could vote as early as Wednesday on a measure withdrawing U.S. support for the Saudi intervention in Yemen's civil war, a move that could put them at odds with the White House.
Washington, DC – Today, Representatives Ro Khanna (CA-17), Mark Pocan (WI-02), and Jim McGovern (MA-02), leaders of H. Con Res.
The Congressional Progressive Caucus, which has historically lacked the clout of other values-based congressional factions, is making a serious play for influence in the next Congress.
In the recent midterm elections, the caucus' political action committee spent more than three times what it spent in the previous election cycle.
On this week's interview episode, Nilay is joined by Rep. Ro Khanna (D-CA) and Verge policy reporter Makena Kelly to discuss Congress' plans to regulate Big Tech in the new year.
The recent confirmation of Brett Kavanaugh to the Supreme Court and Republicans' 2016 stonewalling of Merrick Garland have upended liberals' view of the Supreme Court as a protector of key constitutional rights. Now, progressives are starting to talk about how to challenge the power of the sitting Supreme Court.
U.S. Rep. Ro Khanna (D- Calif.) introduced a legislation to award the Congressional Gold Medal to civil rights icon the Rev. James Lawson, who celebrated his 90th birthday this year.
The legislation was introduced on November 14 with more than two dozen co-sponsors.
Santa Clara, Ca. – At a time when one in five American adults cannot afford to get the prescription medication they need, U.S. Rep. Ro Khanna (D-Calif.) and U.S. Sen. Bernie Sanders (I-Vt.) announced they will introduce the Prescription Drug Price Relief Act at the start of the new Congress to significantly reduce prescription drug prices for Americans.
Even as the final votes are being tallied in the midterm elections, it's clear that Democrats' majority in the House next year will be a boon for the Bay Area's congressional delegation.
The problem with prescription drugs is simple: The U.S. government bestows long-term monopolies on pharmaceutical companies, immunizing them from the forces of market competition and public regulation. As a result, Americans shoulder the highest drug prices in the world while receiving significantly poorer public health outcomes than most of the developed world.